STD Expert Hour Webinar – New Frontiers in STI/HIV Prevention and Family Planning: The promise of Multipurpose Prevention Technologies

Wednesday, June 23, 2021

Presented by Bethany Young Holt, PhD, MPH

Learn about the latest developments in the field of Multipurpose Prevention Technologies (MPTs), products that provide contraception along with protection from STIs and/or HIV.

The origins of MPTs and the current research/development pipeline will also be discussed.

Learning Objectives:

  1. Provide evidence of the need for products that simultaneously address multiple health risks, such as HIV, other STIs, and unplanned pregnancy
  2. Introduce and implement Multipurpose Prevention Technologies (MPTs) and the product candidates currently in development for prevention of HIV, other STIs and/or unintended pregnancies
  3. Describe the Initiative for MPTs (IMPT) and its publicly-available tools for tracking the MPT product development pipeline, while summarizing the current pipeline profile, recent scientific breakthroughs, and the potential impact of MPTs for women around the world
  4. Outline next steps for key stakeholders in STI prevention and related health fields, with a focus on tangible priority actions that will help bring MPTs to the hands of end-users

The CPT rules for the use of problem-oriented E/M office visit codes changed significantly on January 1, 2021. Since then, office visits are coded based on levels of medical decision-making or “total time” and the prior rules for using the “three key components” no longer apply. Consequently, Family PACT E/M coding policies were updated in February 2021, as well as the publication of a new policy on coding and billing for counselor services.

Learning Objectives:

  1. List at least six activities that can be counted in the “total time” of a visit when computing E/M level
  2. List each of the 3 elements used in medical decision-making, and give examples of each
  3. Describe the Family PACT policy for coding for a clinician visit and counselor services on the same date of service

Presenter:

  • Michael Policar, MD, MPH

Resources:

Vaccinating Pregnant Individuals

Guidance and procedures from the American College of Obstetricians and Gynecologists (ACOG) about the COVID-19 vaccine for pregnant and lactating individuals.

ACOG logo

Birth Control Methods

Information on birth control methods and Family PACT coverage for current and prospective Family PACT clients.

FamilyPACT logo

Clinical Practice Alert: Emergency Contraception

An overview of and frequently asked questions about emergency contraception (EC). EC represents a “last chance” to prevent unintended pregnancy. Categories of EC are emergency contraceptive pills (ECPs), including ulipristal acetate (UPA) and levonorgestrel (LNG) and the copper intrauterine device (IUD).

Holding an IUD birth control device in hand

Holding an IUD birth control copper coil device in hand, used for contraception –

Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment

Key recommendations for chlamydia and gonorrhea screening and treatment for individuals assigned female at birth.

FamilyPACT logo

Clinical Practice Alert: Cervical Cancer Screening

Key recommendations for cervical cancer screening from the American College of Obstetricians and Gynecologists (ACOG) and the multidisciplinary partnership of the American Cancer Society, the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology.

Providing Family PACT Services During COVID-19 Part 2: Understanding Benefit Changes

September 17, 2020

The ongoing COVID-19 public health emergency has caused a shift from providing exclusively in-person services to a combination of remote and in-person visits, referred to as “hybrid visits”. This webinar will provide an update of how Family PACT services (client encounters) have changed since March, 2020.

The following topics are covered in detail:

  • Medi-Cal/Family PACT policy for telephonic-only remote visits.
  • A series of case studies including contraceptive visits, evaluation of genital tract infections, well person visits, and a colposcopy visit, with an emphasis on coding and billing Family PACT.

Presenters:

Resources

Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice

July 23, 2020

The long-awaited new ASCCP Management Guideline App is now available, as well as the print version of the 2019 Guidelines. The new guidelines are streamlined for ease of use and can be significantly more individualized than the 2012 guidance by integrating information about an individual’s previous screening test and biopsy results, and personal factors such as age and immunosuppression. The guidelines now provide recommended follow up for all 3 available cervical screening strategies.

The following topics are covered in detail:

  • The rationale used in developing the Guidelines
  • How various abnormalities should be managed
  • Interactive demonstrations of how to use the app
  • Specific considerations for the application of Family PACT benefits, including coding and billing

Learning objectives: At the end of this session, the learner will be able to:

  1. Describe the risk-based paradigm for managing abnormal cervical cancer screening test results.
  2. Explain how risk-thresholds guide the clinical actions of immediate treatment, colposcopy, and short-interval follow up.
  3. Demonstrate use of the ASCCP app to apply the new guidelines to patient care.

Presenters:

Resources

Providing Family PACT Services During COVID-19 Part 1: Clinical Considerations

May 8, 2020

Since March 2020, most providers of family planning services in California have shifted patient care from in-person visits to remote visits. This webinar will be conducted in a “frequently asked questions” format, focusing on the adaptations that clinicians should make in order to successfully provide family planning care remotely during the public health emergency and afterward.

The following topics are covered in detail:

  • Subjects will include the role of blood pressure measurement before prescribing combined hormonal contraception
  • The use of injectable birth control subcutaneous depot medroxyprogesterone acetate (DMPA-SQ)
  • Syndromic treatment of sexually transmitted infections
  • Pregnancy testing without a clinic visit.
  • Recently enacted Family PACT and Medi-Cal policies regarding telehealth visits and remote enrollment of clients into the Family PACT program.

Presenters:

Resources